Professor Luke Howard
Respiratory Consultant
About Luke Howard
Professor Howard has expertise in diseases of pulmonary circulation, including pulmonary hypertension (high blood pressure in the lung) and pulmonary embolism (blood clots in the lung); sport and exercise physiology; unexplained breathlessness.
Alongside his work at Welbeck, Professor Howard is a Consultant Pulmonologist at Imperial College Healthcare NHS Trust and Director of Pulmonary Hypertension Service and a Clinical lead for exercise physiology. Professor Howard is also a Professor of Practice (Cardiopulmonary Medicine) at the National Heart & Lung Institute, Imperial College London. He is also an honorary Consultant Pulmonologist at St Bartholomew’s Hospital.
Personal Biography
Professor Luke Howard completed his undergraduate training in Physiological Sciences at the University of Oxford, which he followed directly with his research doctorate, also at Oxford, in Altitude Physiology. He moved to the University of Cambridge to complete his clinical studies. He acquired his general medical training in London at the Royal Brompton Hospital and Guys and St Thomas’ Hospital and then undertook specialist training in Cambridge and Papworth before moving back to London to take up his current consultant position.
Professor Howard was appointed Consultant Pulmonologist to the National Pulmonary Hypertension Service at Hammersmith Hospital, Imperial College Healthcare NHS Trust, London in 2006. He also runs the Exercise Physiology Service, based at Hammersmith Hospital.
He has an active research programme in Pulmonary Hypertension and Exercise Physiology, as well as sitting on national and international committees and guideline groups for pulmonary hypertension, pulmonary embolism, oxygen therapy and air travel. He is regarded as an international expert, lecturing around the world in his areas of interest.
Expertise
- Unexplained Breathlessness and Exercise Intolerance
- Pulmonary Embolism
- Pulmonary Hypertension
- Exercise Testing and Right Heart Catheterisation
Overview
- Age of patients seen
- 18+
- Languages spoken
- English
- Online profiles
- Research highlights
Main research interests
Early phase clinical studies in pulmonary hypertension examining new targets with novel clinical end-points.
Use of implantable and wearables in health, wellness and clinical trials
The role of exercise testing in assessment of health and disease
Notable Publications
Samaranayake CB, Upham J, Tran K, Howard LS, Nguyen S, Lwin M, Anderson J, Wahi S, Price LC, Wort S, Li W, McCabe C and Keir GJ. Right ventricular functional recovery assessment with stress echocardiography and cardiopulmonary exercise testing after pulmonary embolism: a pilot prospective multicentre study. BMJ Open Respir Res. 2023;10.
Howard LS, Kiely DG, Lawrie A, Maron BA, Preston IR, Rosenkranz S, Toshner M, Wilkins MR, Fong YL, Quinn D, Stamatiadis D, Villeneuve M and Chin KM. Performance of Guideline-Recommended Approaches to Echocardiographic Investigation for Pulmonary Hypertension: Analysis of the CIPHER Study. Pulm Circ. 2026;16:e70258
Bunclark K, Newman J, Ghani H, Munagala S, Otter E, Fischer G, Kurzyna M, Meszaros G, Stone M, Moledina S, Howard L, Gin-Sing W, Ferrari P, Beghetti M, Toshner M, Granato M, Consortium PG and Pepke-Zaba J. The Pulmonary Hypertension Global Patient Survey: Physical and Psychosocial Impacts on Health-Related Quality of Life. Pulm Circ. 2026;16:e70264.
Sitbon O, Sahay S, Escribano Subias P, Zolty RL, Kingrey JF, Ryan JJ, Sobol I, Sood N, Benza RL, Channick RN, Chin KM, Frantz RP, Ghofrani HA, Hemnes AR, McLaughlin VV, Vachiery JL, Zamanian RT, Ter Veer A, Roscigno RF, Mottola D, Parsley E, Aranda R, Zisman LS, Howard LS and Investigators TS. Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study. Adv Ther. 2025;42:5104-5123.
Rothman AMK, Villar SS, Middleton J, Roussakis AA, Varian F, Zafar H, Law M, Apperley J, Bartelink IH, Said MM, Delgado-SanMartin JA, Kiely DG, Howard L, Toshner M, Wort SJ and Wilkins MR. Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study. Am J Respir Crit Care Med. 2025;211:1018-1027.
Boucly A, Song S, Keles M, Wang D, Howard LS, Humbert M, Sitbon O, Lawrie A, Thompson AAR, Frank P, Kivimaki M, Rhodes CJ and Wilkins MR. Clustering Patients with Pulmonary Hypertension Using the Plasma Proteome. Am J Respir Crit Care Med. 2025;211:1492-1503.
Hull JH, Burns P, Carre J, Haines J, Hepworth C, Holmes S, Jones N, MacKenzie A, Paton JY, Ricketts WM and Howard LS. BTS clinical statement for the assessment and management of respiratory problems in athletic individuals. Thorax. 2022;77:540-551.
Baccelli A, Rinaldo RF, Haji G, Davies RJ, Lo Giudice F, Gin-Sing W, Vigo B, Centanni S, Gibbs JSR and Howard LS. Prognostic value of cardiopulmonary exercise testing in pulmonary arterial hypertension. Eur Respir J. 2025;66
De Bie E, Correa-Jaque P, Jones R, Bogaard HJ, Chan J, Church C, Coghlan JG, Gaur A, Ghio S, Ghofrani HA, Goh ZM, Howard LS, Humbert M, Kovacs G, Lawrie A, Lordan J, Lin WY, Neelam-Naganathan D, Newman J, Rhodes CJ, Sheares K, Sitbon O, Willis TW, Wort SJ, Graf S, Kiely DG, Benza RL, Rothman A, Wallace C, Toshner M and Aspire Registry UKPAHCCUCTN. Inflammation and Obesity Correlate in Pulmonary Hypertension but Are Associated with Diverging Outcomes. Am J Respir Crit Care Med. 2026;212:117-128.
Baccelli A, Haji G, Tighe H and Howard LS. Safety of cardiopulmonary exercise testing in pulmonary hypertension: insights from a UK tertiary referral centre. Eur Respir J. 2026;67.
- Professional memberships
Fellow of Royal College of Physicians
Member of European Respiratory Society and British Thoracic Society
- Certifications and Awards
National Clinical Excellence Award - Bronze April 2013
National Clinical Excellence Award - Silver April 2017
National Clinical Excellence Award - Gold April 2021
William Harvey Scholarship - University of Cambridge 1994
Consultations and services
- Self-pay available from £295
- Health insurance
- 30 mins consultation
- Self-pay available from £195
- Health insurance
- 15 mins consultation
Insurers covered
Tests & treatments
Conditions & symptoms
Locations
Loading
Frequently asked questions
Yes, but only for certain services. Some consultations, assessments, and treatments can be booked directly, while others require a GP or specialist referral. Please check the relevant service page for guidance, and contact the centre if you’re unsure.
We aim to offer appointments as quickly as possible, and many services have same-day or next-day availability. Waiting times vary depending on the appointment type, specialty, and consultant availability, but our team will always offer the earliest suitable appointment.
Yes. You can arrange an appointment for a family member, or someone you care for, just let us know when you get in touch. We’ll need their details and consent to complete the booking, unless you're their legal guardian or have power of attorney.
Your first consultation includes a detailed discussion of your symptoms, medical history, and lifestyle factors, followed by a thorough examination. It’s helpful if you can bring the results of any previous investigations with you, as well as a list of your current medications. Come with a comfortably full bladder so you can provide a urine sample if requested.